Deal Announcements

Expression Genetics Nets Second Financing

Wednesday, August 06, 2008 6:04:00 AM PDT | VentureDeal Staff

Huntsville, Alabama --  Biotechnology company Expression Genetics said that it has secured $12 million in its series B round of financing.

The company develops polymeric delivery vehicles based on synthetic biocompatible polymeric systems that deliver therapeutic genes, inhibitory RNA and small molecules.

The investors in the round were not disclosed.  The company said it would use the funding to continue development of its lead product EGEN-101, a cancer therapeutic.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1